List of works - Gloria Selabe

Active co-infection with HBV and/or HCV in South African HIV positive patients due for cancer therapy.

scientific article

Characterization of HCV genotype 5a envelope proteins: implications for vaccine development and therapeutic entry target.

scientific article

Complete genome analysis of hepatitis B virus in human immunodeficiency virus infected and uninfected South Africans.

scientific article

Detection, genotyping and quantitation of multiple hpv infections in south African women with cervical squamous cell carcinoma

scientific article published on 2 June 2015

Evidence for a change in the epidemiology of hepatitis B virus infection after nearly two decades of universal hepatitis B vaccination in South Africa.

scientific article published on 23 February 2014

Evidence of susceptibility to lamivudine-based HAART and genetic stability of hepatitis B virus (HBV) in HIV co-infected patients: A South African longitudinal HBV whole genome study.

scientific article published on 28 May 2016

Functional analysis of 'a' determinant mutations associated with occult HBV in HIV-positive South Africans.

scientific article published on 31 March 2016

Genetic characterization of HIV before widespread testing of HIV vaccine candidates at a clinical trial site in Pretoria, South Africa

scientific article published on 6 March 2012

Hepatitis B virus infection in post-vaccination South Africa: occult HBV infection and circulating surface gene variants

scientific article

Identification and genetic characterization of unique HIV-1 A1/C recombinant strain in South Africa

scientific article

Introduction of new subtypes and variants of hepatitis C virus genotype 4 in South Africa ⬇️

scientific article published on April 1, 2012

Low prevalence of transmitted genetic drug resistance in a cohort of HIV infected naïve patients entering antiretroviral treatment programs at two sites in northern South Africa

scientific article

Mutations associated with lamivudine-resistance in therapy-naïve hepatitis B virus (HBV) infected patients with and without HIV co-infection: implications for antiretroviral therapy in HBV and HIV co-infected South African patients.

scientific article published in November 2007

Mutations associated with occult hepatitis B in HIV-positive South Africans

scientific article

Near full-length genome analysis of HCV genotype 5 strains from South Africa.

scientific article published on 9 November 2013

Prediction of T-cell epitopes of hepatitis C virus genotype 5a

scientific article

List of works by Gloria Selabe

Active co-infection with HBV and/or HCV in South African HIV positive patients due for cancer therapy.

Characterization of HCV genotype 5a envelope proteins: implications for vaccine development and therapeutic entry target.

Complete genome analysis of hepatitis B virus in human immunodeficiency virus infected and uninfected South Africans.

Detection, genotyping and quantitation of multiple hpv infections in south African women with cervical squamous cell carcinoma

Evidence for a change in the epidemiology of hepatitis B virus infection after nearly two decades of universal hepatitis B vaccination in South Africa.

Evidence of susceptibility to lamivudine-based HAART and genetic stability of hepatitis B virus (HBV) in HIV co-infected patients: A South African longitudinal HBV whole genome study.

Functional analysis of 'a' determinant mutations associated with occult HBV in HIV-positive South Africans.

Genetic characterization of HIV before widespread testing of HIV vaccine candidates at a clinical trial site in Pretoria, South Africa

Hepatitis B virus infection in post-vaccination South Africa: occult HBV infection and circulating surface gene variants

Identification and genetic characterization of unique HIV-1 A1/C recombinant strain in South Africa

Introduction of new subtypes and variants of hepatitis C virus genotype 4 in South Africa ⬇️

Low prevalence of transmitted genetic drug resistance in a cohort of HIV infected naïve patients entering antiretroviral treatment programs at two sites in northern South Africa

Mutations associated with lamivudine-resistance in therapy-naïve hepatitis B virus (HBV) infected patients with and without HIV co-infection: implications for antiretroviral therapy in HBV and HIV co-infected South African patients.

Mutations associated with occult hepatitis B in HIV-positive South Africans

Near full-length genome analysis of HCV genotype 5 strains from South Africa.

Prediction of T-cell epitopes of hepatitis C virus genotype 5a